BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.87B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$2.2B |
| 3 |
Amazon
AMZN
|
+$1.9B |
| 4 |
NVIDIA
NVDA
|
+$1.86B |
| 5 |
Costco
COST
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.53B |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$1.81B |
| 3 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$732M |
| 4 |
Super Micro Computer
SMCI
|
+$728M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.8% |
| 2 | Healthcare | 12.59% |
| 3 | Financials | 12.24% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Industrials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
First Guaranty Bancshares
FGBI
$139M
| $213K | ﹤0.01% |
20,999
-1,183
| -5% | -$13.5K |
|
4352
Cohen & Co
COHN
$37.6M
| $207K | ﹤0.01% |
28,962
-52
| -0.2% | -$367 |
|
4353
Cosmos Holdings
COSM
$13.9M
| $207K | ﹤0.01% |
291,069
+370
| +0.1% | +$337 |
|
|
HEPA
4354
DELISTED
Hepion Pharmaceuticals
HEPA
| $207K | ﹤0.01% |
1,659
| – | – |
|
|
BMTX
4355
DELISTED
BM Technologies, Inc.
BMTX
| $206K | ﹤0.01% |
125,039
-470
| -0.4% | -$904 |
|
|
HOOK
4356
DELISTED
HOOKIPA Pharma
HOOK
| $206K | ﹤0.01% |
28,929
-498
| -2% | -$3.54K |
|
4357
Red Cat Holdings
RCAT
$1.53B
| $204K | ﹤0.01% |
266,911
-1,872
| -0.7% | -$1.39K |
|
|
NVNO
4358
enVVeno Medical
NVNO
$6.93M
| $204K | ﹤0.01% |
1,071
-19
| -2% | -$3.41K |
|
4359
Schwab US Large-Cap Growth ETF
SCHG
$62.9B
| $202K | ﹤0.01% |
8,732
-592
| -6% | -$13.1K |
|
4360
FingerMotion
FNGR
$17.2M
| $202K | ﹤0.01% |
95,962
-134,115
| -58% | -$343K |
|
4361
Research Solutions
RSSS
$71.9M
| $201K | ﹤0.01% |
63,713
-1,560
| -2% | -$4.48K |
|
4362
Vanguard Morningstar Small-Cap Value ETF
VBR
$38.2B
| $201K | ﹤0.01% |
1,047
+286
| +38% | +$51.6K |
|
4363
First National Corp
FXNC
$284M
| $200K | ﹤0.01% |
12,296
-758
| -6% | -$14.6K |
|
4364
MediWound
MDWD
$178M
| $200K | ﹤0.01% |
14,001
+2,559
| +22% | +$35K |
|
|
STRM
4365
DELISTED
Streamline Health Solutions
STRM
| $199K | ﹤0.01% |
27,649
-159
| -0.6% | -$1.1K |
|
4366
CF Bankshares
CFBK
$231M
| $199K | ﹤0.01% |
9,943
-1,042
| -9% | -$22K |
|
4367
Rani Therapeutics
RANI
$87.7M
| $198K | ﹤0.01% |
63,583
| – | – |
|
4368
Key Tronic
KTCC
$45.6M
| $197K | ﹤0.01% |
42,298
-580
| -1% | -$2.65K |
|
4369
Hanover Bancorp
HNVR
$191M
| $197K | ﹤0.01% |
13,288
+183
| +1% | +$3.1K |
|
|
RGLS
4370
DELISTED
Regulus Therapeutics
RGLS
| $196K | ﹤0.01% |
68,031
+67,458
| +11,773% | +$110K |
|
|
AWH
4371
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $195K | ﹤0.01% |
62,766
| – | – |
|
|
IRD
4372
Opus Genetics
IRD
$312M
| $194K | ﹤0.01% |
96,714
+2,393
| +3% | +$6.07K |
|
4373
SurgePays
SURG
$7.48M
| $194K | ﹤0.01% |
50,436
+549
| +1% | +$3.66K |
|
4374
Dare Bioscience
DARE
$21M
| $194K | ﹤0.01% |
33,008
-546
| -2% | -$2.67K |
|
4375
Precipio
PRPO
$40.7M
| $194K | ﹤0.01% |
28,912
-60
| -0.2% | -$378 |
|
Similar funds
BlackRock's Q1 2024 Portfolio in Review
As of Q1 2024, BlackRock held 5,499 positions worth $4.3T, up 9.5% from $3.92T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
BlackRock's Q1 2024 filing shows 129 new, 1,833 increased, 2,801 reduced and 210 closed positions. Its largest new stake was Arcadium Lithium plc: 122,471,992 shares worth $528M. The largest sale was iShares Core S&P 500 ETF, an estimated $2.53B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q1 2024 buy was Arcadium Lithium plc: 122,471,992 shares worth $528M.
- BlackRock added most to Microsoft in Q1 2024, an estimated $2.87B increase.
- BlackRock's biggest Q1 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $2.53B.
- BlackRock fully exited Splunk Inc in Q1 2024, selling an estimated $1.81B.
- BlackRock's ten largest holdings make up 24% of its $4.3T portfolio in Q1 2024.
- BlackRock opened 129 new positions and closed 210 in Q1 2024.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $4.3T.
Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.